Impurity Identification
& Characterization

An interdisciplinary team offering precise and versatile Identification & Characterization services.

Resolian excels in Impurity Identification & Characterization, offering comprehensive solutions regardless of your sample matrix.

An interdisciplinary Impurity Identification & Characterization team collaborates closely with Analytical Chemistry & Trace AnalysisExtractables & Leachables, and Foreign Matter Analysis teams to identify critical degradation products throughout the development cycle.

Incorporating advanced instrumentation, Resolian specializes in the structural elucidation of active components and process impurities during all phases of development lifecycle for both small and large molecules.

These innovative approaches provide online separation and detection of compounds, expanding capabilities to tackle your impurity identification challenges comprehensively.

Reach out to us directly to learn more about Impurity Identification & Characterization services.

 

Services in Detail

Impurity Identification Regardless of Matrix: Offering you expertise to identify and characterize impurities in diverse matrices, from macroscopic particles to the smallest chemical components.

Visible/Subvisible Particles: Resolian’s Foreign Matter Analysis team excels in handling visible and subvisible particles, ensuring thorough analysis.

Non-Volatile Components: Resolian employs cutting-edge technologies for both small molecules and large biomolecules in highly complex formulations, including UPLC-IM-HRAMS and 2D-UPLC-HRAMS, enabling confident characterization.

Semi-Volatile Components: Resolian utilizes CI and EI GC-MS complementing the identification of semi-volatile components, ensuring a comprehensive impurity profile.

VOCs and VVOCs Identification: Resolian’s HS-GC-MS, equipped with cryogenic capabilities, facilitates the identification of very volatile organic compounds (VVOCs).

Our
Resources

Our Resources

Biomarker Assay List

Bioanalytical LC-MS/MS Assay List 

Immunoassay Pharmacokinetics

Scroll to Top

Zhiyang Zhao, Ph.D.

Chief Scientific Officer

Zhiyang Zhao, Ph.D., serves as Chief Scientific Officer (CSO) at Resolian. Dr. Zhao has over 30 years of pharmaceutical industry experience with special focus on drug metabolism and bioanalysis of small and large molecules in drug discovery and development. Dr. Zhao has previously held positions at Pfizer, GlaxoSmithKline, and Amgen. Before joining Resolian in 2015, Dr. Zhao served as Site Director of Preclinical Research at Amgen in Cambridge, Massachusetts, for over a decade. 

Currently, Dr. Zhao serves as an Adjunct Professor at the Eshelman School of Pharmacy of the University of North Carolina at Chapel Hill, North Carolina, and as Editor-in-Chief of Drug Metabolism & Bioanalysis Letters, a journal by Bentham Science, which publishes in all areas of drug metabolism and bioanalysis. Dr. Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Polytechnic and State University (popularly known as Virginia Tech) in Blacksburg, Virginia. 

Patrick Bennett

Chief Executive Officer

Patrick Bennett has over 35 years of experience in pharmaceutical analysis and laboratory management. Now CEO at Resolian, Patrick’s experience includes the roles of Strategic Marketing Director for Pharma with Thermo Fisher Scientific, LabCorp, and Vice President of Strategy and Development with PPD. 

Patrick earned a B.S. degree in Toxicology and a M.S. degree in Pharmacology from the College of Pharmacy and Allied Health at St. John’s University and an M.B.A in International Marketing from the Martin J. Whitman School of Management at Syracuse University.